Clinical Trial Update: Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With Diabetes

View source ↗

Summary

This clinical trial update evaluates cancer risk associated with becaplermin use in a U.S. veteran population with diabetes and foot ulcers; results inform safe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Foot Ulcer
• Diabetic Neuropathy

Drugs mentioned

• Becaplermin (Regranex) (becaplermin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Diabetes Mellitus, Foot Ulcer | Status: COMPLETED